<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7513902\results\search\disease\results.xml">
  <result pre="University, [3], grid.216417.70000 0001 0379 7164Department of Pharmacy, Xiangya Hospital," exact="Central" post="South University, [4], epub: 2020-9-9111received: 2020-5-8accepted: 2020-9-11(C) , This"/>
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="of COVID-19 as a global pandemic. Abstract Background The Coronavirus" exact="Disease" post="2019 (COVID-19) is a new, highly infective virus. In"/>
  <result pre="Background The Coronavirus Disease 2019 (COVID-19) is a new, highly" exact="infective" post="virus. In the absence of specific vaccines and antiviral"/>
  <result pre="2019 (COVID-19) is a new, highly infective virus. In the" exact="absence of" post="specific vaccines and antiviral drugs, the China National Health"/>
  <result pre="has released a series of COVID-19 treatment guidelines, which include" exact="symptomatic" post="treatment, antiviral treatment, and traditional Chinese medicines (TCM). Aim"/>
  <result pre="properties, and they have certain advantages in the treatment of" exact="viral pneumonia" post="and other emergent infectious diseases. Many TCMs also have"/>
  <result pre="and they have certain advantages in the treatment of viral" exact="pneumonia" post="and other emergent infectious diseases. Many TCMs also have"/>
  <result pre="advantages in the treatment of viral pneumonia and other emergent" exact="infectious diseases." post="Many TCMs also have potent anti-inflammatory and immunomodulatory effects."/>
  <result pre="also have potent anti-inflammatory and immunomodulatory effects. Treatment based on" exact="syndrome" post="differentiation is one of the significant features in TCM."/>
  <result pre="pathways. Treatment of COVID-19 using TCMs can be based on" exact="syndrome" post="differentiation, a unique feature of traditional Chinese medicine. Traditional"/>
  <result pre="treatment of COVID-19 based on TCM theories. Introduction Novel coronavirus" exact="pneumonia" post="(COVID-19) is highly infectious and has caused widespread infection"/>
  <result pre="on TCM theories. Introduction Novel coronavirus pneumonia (COVID-19) is highly" exact="infectious" post="and has caused widespread infection [1, 2]. To guide"/>
  <result pre="coronavirus pneumonia (COVID-19) is highly infectious and has caused widespread" exact="infection" post="[1, 2]. To guide the diagnosis and treatment of"/>
  <result pre="clinical manifestations [6]. TCM has a long history in treating" exact="infectious diseases" post="in China. TCM can rapidly improve symptoms and reduce"/>
  <result pre="rapidly improve symptoms and reduce the occurrence of complications through" exact="syndrome" post="differentiation. Syndrome differentiation is a summary of the pathological"/>
  <result pre="symptoms and reduce the occurrence of complications through syndrome differentiation." exact="Syndrome" post="differentiation is a summary of the pathological signs of"/>
  <result pre="pathological signs of the body at a specific stage during" exact="disease" post="development, based on the data collected by the synthesis"/>
  <result pre="the most abundant sources in China. Studies and reviews were" exact="limited" post="to those in English or Chinese concerning the use"/>
  <result pre="as search strategy and modified according to different databases: (â€œcoronavirus" exact="disease" post="2019â€� OR â€œCOVID-19â€� OR â€œSARS-CoV-2â€� OR â€œnovel coronavirus pneumoniaâ€�"/>
  <result pre="of COVID-19 from TCM perspectives COVID-19 is considered a febrile" exact="disease" post="and epidemic in TCM. The patientsâ€™ clinical symptoms and"/>
  <result pre="treatment have been summarized in the NHC guidelines. According to" exact="disease" post="development, the clinical stages of COVID-19 are divided into"/>
  <result pre="manifestation Medical observation period Clinical manifestation 1 Hypodynamia and gastrointestinal" exact="discomfort" post="Clinical manifestation 2 Hypodynamia and fever Treatment period Light"/>
  <result pre="encumbering the lung: fever, hypodynamia, body aches, cough, expectoration, tight" exact="chest" post="and breathless, anorexia, nausea, vomiting, loose stool, tongue bearing"/>
  <result pre="chest and breathless, anorexia, nausea, vomiting, loose stool, tongue bearing" exact="dental" post="impressions or red, white fur, soggy pulse or slippery"/>
  <result pre="tongue, light-colored tongue with white and slippery coating, soggy pulse" exact="Severe" post="Pattern of epidemic toxin internal block: fever and blush,"/>
  <result pre="pulse TCM traditional Chinese medicine In the NHC guidelines, a" exact="total" post="of 15 TCMs are recommended, of which 7 are"/>
  <result pre="Version 6 Version 7 Angong Niuhuang pill Inner blocking causing" exact="collapse" post="Zixue powder Inner blocking causing collapse Huoxiang Zhengqi capsule"/>
  <result pre="pill Inner blocking causing collapse Zixue powder Inner blocking causing" exact="collapse" post="Huoxiang Zhengqi capsule (pill, water, oral liquid) Medical observation"/>
  <result pre="Jinhua Qinggan has traditionally been used for the treatment of" exact="plague" post="diseases. However, clinical studies have shown that it has"/>
  <result pre="clinical studies have shown that it has therapeutic efficacy against" exact="viral" post="infections. In 2011, a clinical trial with 403 patients"/>
  <result pre="fatigue, sputum, anxiety, and the hospitalization rate tended to be" exact="lower" post="than in the control group [13]. Although a randomized"/>
  <result pre="immune regulation through targets such as mitogen-activated protein kinase and" exact="Hepatitis" post="B signaling pathways [15]. It can inhibit the release"/>
  <result pre="the lung tissue damage caused by inflammation [16]. The lung" exact="infection" post="is related to lung immunity, and Lianhua Qingwen can"/>
  <result pre="indicated the role of Lianhua Qingwen in treating new coronavirus" exact="pneumonia" post="[18]. One study enrolled 102 COVID-19 patients (1:1 ratio),"/>
  <result pre="group (91.5% vs. 82.4%,Â Pâ€‰=â€‰0.022). The rate of improvement in" exact="chest" post="CT (83.8% vs. 64.1%,Â Pâ€‰ Pâ€‰=â€‰0.017) were also higher"/>
  <result pre="clinical observation period and in the early stage of the" exact="disease" post="(mild case) in the NHC guidelines [6]. Shufeng Jiedu"/>
  <result pre="capsules (granules) Shufeng JieduÂ capsules (granules) are mainly used for" exact="acute" post="upper respiratory tract infections. The granules consist of polygonum"/>
  <result pre="(granules) Shufeng JieduÂ capsules (granules) are mainly used for acute" exact="upper" post="respiratory tract infections. The granules consist of polygonum cuspidatum,"/>
  <result pre="Shufeng JieduÂ capsules (granules) are mainly used for acute upper" exact="respiratory" post="tract infections. The granules consist of polygonum cuspidatum, forsythia,"/>
  <result pre="It has an inhibitory effect on influenza-A virus H1N1 type," exact="herpes" post="simplex virus type 1 and 2, respiratory syncytial virus,"/>
  <result pre="inhibitory effect on influenza-A virus H1N1 type, herpes simplex virus" exact="type 1" post="and 2, respiratory syncytial virus, parainfluenza virus, Coxsackievirus B4,"/>
  <result pre="virus H1N1 type, herpes simplex virus type 1 and 2," exact="respiratory" post="syncytial virus, parainfluenza virus, Coxsackievirus B4, Coxsackievirus B5, and"/>
  <result pre="through reducing the level of lactic acid, increasing the oxygen" exact="partial" post="pressure in the lung tissue, promoting the absorption of"/>
  <result pre="partial pressure in the lung tissue, promoting the absorption of" exact="lung inflammation," post="and relieving local symptoms. It plays an active role"/>
  <result pre="symptoms. It plays an active role in the treatment of" exact="viral pneumonia." post="The biological approach of Shufeng Jiedu in the treatment"/>
  <result pre="patients during the clinical observation and early stages of the" exact="disease" post="(mild case) in the NHC guidelines [6]. Application of"/>
  <result pre="is clinically used for the treatment of bronchitis, tonsillitis, and" exact="bacterial disease." post="Its main component is an andrographolide compound [25]. The"/>
  <result pre="bonds determine their anti-inflammatory activity [26]. In 20 patients with" exact="acute" post="bronchopneumonia treated with andrographolide injection, andrographolide can directly act"/>
  <result pre="survival rate of infected animals, reduce pathological lung changes, reduce" exact="viral" post="load, and reduce inflammatory cytokine expression [28]. Xiyanping can"/>
  <result pre="and rales in the lungs [29]. Discussed benefits include inhibiting" exact="viral" post="replication and infection, inhibiting concurrent bacterial infections, improving the"/>
  <result pre="Discussed benefits include inhibiting viral replication and infection, inhibiting concurrent" exact="bacterial infections," post="improving the body's immunity, and improving liver function and"/>
  <result pre="infections, improving the body's immunity, and improving liver function and" exact="cardiovascular" post="damage. However, there are no reported clinical studies in"/>
  <result pre="miltiorrhiza, and angelica [30]. It is indicated to treat sepsis," exact="systemic" post="inflammatory response syndrome, and multiple organ dysfunction syndromes (MODS)"/>
  <result pre="Xuebijing is widely used in China for treating severe pneumonia," exact="chronic" post="obstructive pulmonary disease, acute respiratory distress syndrome, and other"/>
  <result pre="widely used in China for treating severe pneumonia, chronic obstructive" exact="pulmonary" post="disease, acute respiratory distress syndrome, and other critical conditions/diseases."/>
  <result pre="in China for treating severe pneumonia, chronic obstructive pulmonary disease," exact="acute" post="respiratory distress syndrome, and other critical conditions/diseases. The combined"/>
  <result pre="China for treating severe pneumonia, chronic obstructive pulmonary disease, acute" exact="respiratory" post="distress syndrome, and other critical conditions/diseases. The combined application"/>
  <result pre="has been found that adding Xuebijing to patients with severe" exact="pneumonia" post="based on conventional treatment can reduce the levels of"/>
  <result pre="retrospective method, researchers investigated 44 patients with light new coronavirus" exact="pneumonia" post="[32]. Patients were divided into an observation group (nâ€‰=â€‰22)"/>
  <result pre="effects [33]. It has proven efficacy in the treatment of" exact="acute" post="bronchitis and upper respiratory tract infections. Therefore, it has"/>
  <result pre="[33]. It has proven efficacy in the treatment of acute" exact="bronchitis" post="and upper respiratory tract infections. Therefore, it has become"/>
  <result pre="has proven efficacy in the treatment of acute bronchitis and" exact="upper" post="respiratory tract infections. Therefore, it has become a recommended"/>
  <result pre="proven efficacy in the treatment of acute bronchitis and upper" exact="respiratory" post="tract infections. Therefore, it has become a recommended anti-epidemic"/>
  <result pre="Reduning has a good therapeutic effect on lung injury and" exact="cardiovascular disease." post="However, there are no reported clinical studies in the"/>
  <result pre="is mainly used in the clinical treatment of early pneumonia," exact="acute" post="bronchitis, acute exacerbation of chronic bronchitis, and lower respiratory"/>
  <result pre="used in the clinical treatment of early pneumonia, acute bronchitis," exact="acute" post="exacerbation of chronic bronchitis, and lower respiratory tract infections"/>
  <result pre="clinical treatment of early pneumonia, acute bronchitis, acute exacerbation of" exact="chronic bronchitis," post="and lower respiratory tract infections [37]. Quercetin and luteolin"/>
  <result pre="early pneumonia, acute bronchitis, acute exacerbation of chronic bronchitis, and" exact="lower" post="respiratory tract infections [37]. Quercetin and luteolin in Tanreqing"/>
  <result pre="pneumonia, acute bronchitis, acute exacerbation of chronic bronchitis, and lower" exact="respiratory" post="tract infections [37]. Quercetin and luteolin in Tanreqing have"/>
  <result pre="bronchitis, acute exacerbation of chronic bronchitis, and lower respiratory tract" exact="infections" post="[37]. Quercetin and luteolin in Tanreqing have anti-influenza A"/>
  <result pre="and other ingredients [41]. It is commonly used clinically for" exact="acute" post="poisoning, viral encephalitis, craniocerebral injury, acute cerebrovascular disease, pulmonary"/>
  <result pre="ingredients [41]. It is commonly used clinically for acute poisoning," exact="viral encephalitis," post="craniocerebral injury, acute cerebrovascular disease, pulmonary encephalopathy, pneumonia, respiratory"/>
  <result pre="commonly used clinically for acute poisoning, viral encephalitis, craniocerebral injury," exact="acute" post="cerebrovascular disease, pulmonary encephalopathy, pneumonia, respiratory failure, and sepsis"/>
  <result pre="used clinically for acute poisoning, viral encephalitis, craniocerebral injury, acute" exact="cerebrovascular disease," post="pulmonary encephalopathy, pneumonia, respiratory failure, and sepsis [42]. Studies"/>
  <result pre="for acute poisoning, viral encephalitis, craniocerebral injury, acute cerebrovascular disease," exact="pulmonary" post="encephalopathy, pneumonia, respiratory failure, and sepsis [42]. Studies have"/>
  <result pre="viral encephalitis, craniocerebral injury, acute cerebrovascular disease, pulmonary encephalopathy, pneumonia," exact="respiratory" post="failure, and sepsis [42]. Studies have compared the antipyretic"/>
  <result pre="have compared the antipyretic effects of Xingnaojing and Qingkailing on" exact="upper respiratory tract infection" post="in adults [43]. The results showed that the total"/>
  <result pre="compared the antipyretic effects of Xingnaojing and Qingkailing on upper" exact="respiratory" post="tract infection in adults [43]. The results showed that"/>
  <result pre="antipyretic effects of Xingnaojing and Qingkailing on upper respiratory tract" exact="infection" post="in adults [43]. The results showed that the total"/>
  <result pre="tract infection in adults [43]. The results showed that the" exact="total" post="effective rate in the Xingnaojing treatment group was 91.4%,"/>
  <result pre="in the treatment group. Xingnaojing can shorten the progression of" exact="acute" post="infectious fever, especially the infection caused by viruses. It"/>
  <result pre="the treatment group. Xingnaojing can shorten the progression of acute" exact="infectious" post="fever, especially the infection caused by viruses. It can"/>
  <result pre="can shorten the progression of acute infectious fever, especially the" exact="infection" post="caused by viruses. It can significantly reduce the time"/>
  <result pre="Xingnaojing can effectively reduce the level of pro-inflammatory factors in" exact="pneumonia" post="rats, improve the ability to resist oxidative stress, and"/>
  <result pre="of CD3â€‰+â€‰and CD4â€‰+â€‰, and reduce the level of CD8â€‰+â€‰when treating" exact="mycoplasmal pneumonia" post="in the elderly. Also, they can improve the body's"/>
  <result pre="CD3â€‰+â€‰and CD4â€‰+â€‰, and reduce the level of CD8â€‰+â€‰when treating mycoplasmal" exact="pneumonia" post="in the elderly. Also, they can improve the body's"/>
  <result pre="CRP, IL- 6, and TNF-Î± during the adjuvant treatment of" exact="ventilator-associated pneumonia." post="It can also reduce the possibility of an inflammatory"/>
  <result pre="ginseng and black monkshood, commonly used in the treatment of" exact="cardiovascular" post="and cerebrovascular diseases [49]. It can also be used"/>
  <result pre="can reduce the level of IL-6, increase the number of" exact="peripheral" post="blood CD3â€‰+â€‰, CD4â€‰+â€‰, and CD8â€‰+â€‰-T cells, maintain the pro-inflammatory/anti-inflammatory"/>
  <result pre="function [52]. When observing the treatment of Shenfu on elderly" exact="chronic" post="lung infections, it was found that Shenfu can reduce"/>
  <result pre="immune regulation while playing an active role in treating lung" exact="infections" post="[53]. Shenfu combined with antibiotic treatment can shorten the"/>
  <result pre="and von Willebrand factor (vWF), and improve the function of" exact="vascular" post="endothelial cells, while reducing myocardial damage, and enhance blood"/>
  <result pre="cells, while reducing myocardial damage, and enhance blood gas and" exact="respiratory" post="indicators [54]. Shenfu can significantly improve the mean arterial"/>
  <result pre="water index, and other hemodynamic indexes in patients with severe" exact="pneumonia" post="[55]. It can additionally inhibit the HMGB1/NF-ÎºB signaling pathway,"/>
  <result pre="ginseng and ophiopogon japonicus [58]. It is used to treat" exact="coronary heart disease," post="viral myocarditis, chronic pulmonary heart disease, and neutropenia. It"/>
  <result pre="and ophiopogon japonicus [58]. It is used to treat coronary" exact="heart" post="disease, viral myocarditis, chronic pulmonary heart disease, and neutropenia."/>
  <result pre="japonicus [58]. It is used to treat coronary heart disease," exact="viral" post="myocarditis, chronic pulmonary heart disease, and neutropenia. It can"/>
  <result pre="It is used to treat coronary heart disease, viral myocarditis," exact="chronic" post="pulmonary heart disease, and neutropenia. It can improve the"/>
  <result pre="is used to treat coronary heart disease, viral myocarditis, chronic" exact="pulmonary" post="heart disease, and neutropenia. It can improve the immune"/>
  <result pre="used to treat coronary heart disease, viral myocarditis, chronic pulmonary" exact="heart" post="disease, and neutropenia. It can improve the immune function"/>
  <result pre="disease, and neutropenia. It can improve the immune function of" exact="tumor" post="patients. When used in combination with chemotherapy drugs, it"/>
  <result pre="of severe pneumonia. Shenmai improves the cure rate in severe" exact="pneumonia" post="through its anti-inflammatory effects [61]. One study randomly divided"/>
  <result pre="anti-inflammatory effects [61]. One study randomly divided 93 patients with" exact="ventilator-associated pneumonia" post="into three groups. The three groups were given conventional"/>
  <result pre="effects [61]. One study randomly divided 93 patients with ventilator-associated" exact="pneumonia" post="into three groups. The three groups were given conventional"/>
  <result pre="significantly reduced white blood cells, CRP and procalcitonin, and increased" exact="peripheral" post="blood CD4â€‰+â€‰/CD8â€‰+â€‰ratio [62]. In the treatment of sepsis, Shenmai"/>
  <result pre="improve symptoms of critical patients with COVID-19 in terms of" exact="lung inflammation," post="virus infection, and drug-induced disease lung injury. However, there"/>
  <result pre="of critical patients with COVID-19 in terms of lung inflammation," exact="virus infection," post="and drug-induced disease lung injury. However, there are no"/>
  <result pre="COVID-19 in terms of lung inflammation, virus infection, and drug-induced" exact="disease" post="lung injury. However, there are no clinical studies in"/>
  <result pre="chinensis [64]. Shengmai has often been used clinically to treat" exact="cardiovascular" post="and cerebrovascular diseases. When Shengmai combined with conventional treatment"/>
  <result pre="and cerebrovascular diseases. When Shengmai combined with conventional treatment in" exact="systemic" post="inflammatory response syndrome, it can significantly increase the plasma"/>
  <result pre="peptide (ANP) and endothelin (ET) level and improve breathing and" exact="vascular" post="microcirculation. Shengmai plays a protective role in various organs"/>
  <result pre="observed the clinical effect of Shengmai on elderly patients with" exact="pulmonary" post="infections and multiple organ failure. The results showed that"/>
  <result pre="the clinical effect of Shengmai on elderly patients with pulmonary" exact="infections" post="and multiple organ failure. The results showed that adding"/>
  <result pre="lymph nodes in immunosuppressed mice caused by cyclophosphamide, increase the" exact="total" post="volume of splenic white nucleus pulposus lymph node cortex,"/>
  <result pre="improve symptoms of critical patients with COVID-19 in terms of" exact="lung inflammation," post="virus infection, drug-induced disease lung injury. However, there are"/>
  <result pre="of critical patients with COVID-19 in terms of lung inflammation," exact="virus infection," post="drug-induced disease lung injury. However, there are no reported"/>
  <result pre="with COVID-19 in terms of lung inflammation, virus infection, drug-induced" exact="disease" post="lung injury. However, there are no reported clinical studies"/>
  <result pre="the COVID-19 pandemic. TCMâ€™s characteristics, past experiences in treating other" exact="viral" post="infections, and several studies of TCM in treating COVID-19,"/>
  <result pre="on this narrative review, TCM has many advantages in treating" exact="viral pneumonia" post="and other emergent infectious diseases. Many TCMs have potent"/>
  <result pre="this narrative review, TCM has many advantages in treating viral" exact="pneumonia" post="and other emergent infectious diseases. Many TCMs have potent"/>
  <result pre="has many advantages in treating viral pneumonia and other emergent" exact="infectious diseases." post="Many TCMs have potent anti-inflammatory and immunomodulatory effects. Treatment"/>
  <result pre="TCMs have potent anti-inflammatory and immunomodulatory effects. Treatment based on" exact="syndrome" post="differentiation is one of the significant features in TCM"/>
  <result pre="systematic analysis of previous clinical studies on the treatment of" exact="infectious" post="pneumonia by TCM, it has been confirmed that TCM"/>
  <result pre="analysis of previous clinical studies on the treatment of infectious" exact="pneumonia" post="by TCM, it has been confirmed that TCM has"/>
  <result pre="the etiology and pathogenesis are highly similar between COVID-19 and" exact="infectious" post="pneumonia, clinicians can use TCMs to treat COVID-19 by"/>
  <result pre="TCMs to treat COVID-19 by referring to the rules of" exact="infectious" post="pneumonia [69]. Among the oral and injectable TCMs we"/>
  <result pre="to treat COVID-19 by referring to the rules of infectious" exact="pneumonia" post="[69]. Among the oral and injectable TCMs we reviewed,"/>
  <result pre="with a new indication of &quot;treating for the new coronavirus" exact="pneumonia" post="with severe and critical systemic inflammatory response syndrome or/and"/>
  <result pre="&quot;treating for the new coronavirus pneumonia with severe and critical" exact="systemic" post="inflammatory response syndrome or/and multiple organ failure&quot;. Lianhua Qingwen"/>
  <result pre="new coronavirus pneumonia with severe and critical systemic inflammatory response" exact="syndrome" post="or/and multiple organ failure&quot;. Lianhua Qingwen was approved to"/>
  <result pre="well positioned to provide individualized pharmaceutical care based on the" exact="syndrome" post="differentiation of the COVID-19 patient, especially for patients on"/>
  <result pre="widely used in the treatment of COVID-19 in China. Both" exact="limited" post="clinical studies and real-world experiences have indicated the role"/>
  <result pre="pandemicN Engl J Med202038220e5510.1056/NEJMp200511832212515 2.World Health Organize (WHO). WHO coronavirus" exact="disease" post="(COVID-19) Dashboard [Internet]. Geneva: WHO (2020), August 7. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200505covid-19-sitrep-106.pdf?sfvrsn=47090f63_2."/>
  <result pre="(COVID-19) Dashboard [Internet]. Geneva: WHO (2020), August 7. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200505covid-19-sitrep-106.pdf?sfvrsn=47090f63_2. 3.The" exact="General" post="Office of the National Health and Health Commission and"/>
  <result pre="Administration of Traditional Chinese Medicine. Notice on printing and distributing" exact="pneumonia" post="diagnosis and treatment program for new coronavirus infection (Trial"/>
  <result pre="and distributing pneumonia diagnosis and treatment program for new coronavirus" exact="infection" post="(Trial version 4) [Internet]. Beijing: China; 2020 January 28."/>
  <result pre="ISBN: National Health Office Medical Letter (2020) No. 77 4.The" exact="General" post="Office of the National Health and Health Commission and"/>
  <result pre="Administration of Traditional Chinese Medicine. Notice on printing and distributing" exact="pneumonia" post="diagnosis and treatment program for new coronavirus infection (trial"/>
  <result pre="and distributing pneumonia diagnosis and treatment program for new coronavirus" exact="infection" post="(trial version 5) [Internet]. Beijing: China; 2020 February 5."/>
  <result pre="ISBN: National Health Office Medical Letter (2020) No. 117 5.The" exact="General" post="Office of the National Health and Health Commission and"/>
  <result pre="Administration of Traditional Chinese Medicine. Notice on printing and distributing" exact="pneumonia" post="diagnosis and treatment program for new coronavirus infection (trial"/>
  <result pre="and distributing pneumonia diagnosis and treatment program for new coronavirus" exact="infection" post="(trial version 6) [Internet]. Beijing: China; 2020 February 19."/>
  <result pre="ISBN: National Health Office Medical Letter (2020) No. 145 6.The" exact="General" post="Office of the National Health and Health Commission and"/>
  <result pre="Administration of Traditional Chinese Medicine. Notice on printing and distributing" exact="pneumonia" post="diagnosis and treatment program for new coronavirus infection (trial"/>
  <result pre="and distributing pneumonia diagnosis and treatment program for new coronavirus" exact="infection" post="(trial version 7) [Internet]. Beijing: China; 2020 March 4."/>
  <result pre="basic nomenclature of Chinese Medicine2008BeijingChina 9.Li D, Che Z. TCM" exact="syndrome" post="type analysis of 58 cases of new crown pneumonia"/>
  <result pre="TCM syndrome type analysis of 58 cases of new crown" exact="pneumonia" post="in Wuhan square cabin hospital, China. Trace Elem Health"/>
  <result pre="hospital, China. Trace Elem Health Res. 2020;5:40-1. 10.MaJChenMWangYGSummary of TCM" exact="syndrome" post="and treatment of novel coronavirus pneumonia, China. BeijingTradit Chin"/>
  <result pre="of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus" exact="disease" post="2019 (COVID-19): a protocol for systematic review and meta"/>
  <result pre="the effect of Lianhuaqingwen Capsule on the rat models of" exact="chronic" post="obstructive pulmonary disease, ChinaFudan Univ J Med Sci200803441444 17.DingYZengLLiRChenQZhouBChenQet"/>
  <result pre="of Lianhuaqingwen Capsule on the rat models of chronic obstructive" exact="pulmonary" post="disease, ChinaFudan Univ J Med Sci200803441444 17.DingYZengLLiRChenQZhouBChenQet al.The Chinese"/>
  <result pre="prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of" exact="viral" post="propagation and impacts immune functionBMC Complement Altern Med201717113010.1186/s12906-017-1585-728235408 18.YaoKTLiuMYLiXHuangJHCaiHBRetrospective"/>
  <result pre="Qingwen capsules, a repurposed Chinese herb, in patients with coronavirus" exact="disease" post="2019: a multicenter, prospective, randomized controlled trialPhytomedicine20201615324210.1016/j.phymed.2020.153242 21.LiuXZhangHXuJGongSHanYZhangTet al.Identification"/>
  <result pre="of Shufeng Jiedu capsule and oseltamivir in influenza A viral-induced" exact="acute" post="exacerbation of chronic obstructive pulmonary diseaseBiomed Pharmacother202012110965210.1016/j.biopha.2019.10965231734578 23.JiQJShanRYDengSMTianYYChaiWHuangHet al.Effect"/>
  <result pre="capsule and oseltamivir in influenza A viral-induced acute exacerbation of" exact="chronic" post="obstructive pulmonary diseaseBiomed Pharmacother202012110965210.1016/j.biopha.2019.10965231734578 23.JiQJShanRYDengSMTianYYChaiWHuangHet al.Effect of Shu Feng"/>
  <result pre="oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive" exact="pulmonary" post="diseaseBiomed Pharmacother202012110965210.1016/j.biopha.2019.10965231734578 23.JiQJShanRYDengSMTianYYChaiWHuangHet al.Effect of Shu Feng Jiedu capsule"/>
  <result pre="dripping of andrographolide in stabilizing body temperature of children with" exact="acute" post="bronchial pneumonia, ChinaChin Pediatr Integr Tradit Western Med2018102146149 28.DingYChenLZWuWJYangJYangZFLiuSWAndrographolide"/>
  <result pre="of andrographolide in stabilizing body temperature of children with acute" exact="bronchial pneumonia," post="ChinaChin Pediatr Integr Tradit Western Med2018102146149 28.DingYChenLZWuWJYangJYangZFLiuSWAndrographolide inhibits influenza"/>
  <result pre="Pharmacother20191091523153110.1016/j.biopha.2018.10.19030551404 31.DiaoYFZhangSJZhaoWYSunHTZhangSSunLEffect of Xuebijing Injection on expression of interleukin-6 and" exact="tumor" post="necrosis factor-Î± in patients with severe pneumonia, ChinaChin Tradit"/>
  <result pre="of Reduning injection based on signaling pathways and discussion of" exact="disease" post="therapy2015XianNothwest university 34.YanYFanFJZhaoJBaoJYFengLXClinical study on Reduning injection combined with"/>
  <result pre="therapeutic effect of tanreqing injection combined with ceftizoxime sodium for" exact="lower" post="respiratory tract infection, ChinaChin Tradit Herb Drug2009406947948 38.ZhuHChenMShiXShiCHuangCMaterial basis"/>
  <result pre="effect of tanreqing injection combined with ceftizoxime sodium for lower" exact="respiratory" post="tract infection, ChinaChin Tradit Herb Drug2009406947948 38.ZhuHChenMShiXShiCHuangCMaterial basis studies"/>
  <result pre="Drug Resist201920123911392310.2147/IDR.S231908 40.KongYWuHWChenYLaiSYangZMChenJSMechanism of Tanreqing Injection on treatment of coronavirus" exact="disease" post="2019 based on network pharmacology and molecular dockingChina Chin"/>
  <result pre="Western Med2013221719371938 43.WuXLObservation of anti-hyperthermia effect of Xingnaojing injection on" exact="adult" post="upper respiratory tract infection, ChinaShandong Med J20094928108108 44.XuZFWangLJYuZMClinical Study"/>
  <result pre="Med2013221719371938 43.WuXLObservation of anti-hyperthermia effect of Xingnaojing injection on adult" exact="upper respiratory tract infection," post="ChinaShandong Med J20094928108108 44.XuZFWangLJYuZMClinical Study on the intervention effect"/>
  <result pre="43.WuXLObservation of anti-hyperthermia effect of Xingnaojing injection on adult upper" exact="respiratory" post="tract infection, ChinaShandong Med J20094928108108 44.XuZFWangLJYuZMClinical Study on the"/>
  <result pre="44.XuZFWangLJYuZMClinical Study on the intervention effect of Xingnaojing injection on" exact="acute" post="infectious fever, ChinaLingnan J Emerg Med20131813637 45.ZhangJJZhuZYZhangJThe observation on"/>
  <result pre="Study on the intervention effect of Xingnaojing injection on acute" exact="infectious" post="fever, ChinaLingnan J Emerg Med20131813637 45.ZhangJJZhuZYZhangJThe observation on therapeutic"/>
  <result pre="of Xingnaojing injection on serum cytokines in patients with severe" exact="pneumonia" post="in ICU, ChinaChin J Clin Pharm Ther.2007121214281431 49.LiuCHouYWangXZhaoZLiuZZhaiJet al.Clinical"/>
  <result pre="injection loading in the treatment of patients with exacerbation of" exact="chronic" post="heart failure due to coronary heart disease: study protocol"/>
  <result pre="loading in the treatment of patients with exacerbation of chronic" exact="heart" post="failure due to coronary heart disease: study protocol for"/>
  <result pre="patients with exacerbation of chronic heart failure due to coronary" exact="heart" post="disease: study protocol for a randomized controlled trialTrials2015211622210.1186/s13063-015-0729-7 50.ZhangNLiuJHQiuZLYeYPZhangJLouTZShenfu"/>
  <result pre="protocol for an updated systematic reviewMedicine (Baltimore)20199838e1700410.1097/MD.000000000001700431567937 52.YuRClinical observation on" exact="infantile" post="bacterial pneumonia treated by Shenfu injection, ChinaChin Tradit Herb"/>
  <result pre="for an updated systematic reviewMedicine (Baltimore)20199838e1700410.1097/MD.000000000001700431567937 52.YuRClinical observation on infantile" exact="bacterial pneumonia" post="treated by Shenfu injection, ChinaChin Tradit Herb Drug2004351213971398 53.HuQYangWYLongJEffect"/>
  <result pre="an updated systematic reviewMedicine (Baltimore)20199838e1700410.1097/MD.000000000001700431567937 52.YuRClinical observation on infantile bacterial" exact="pneumonia" post="treated by Shenfu injection, ChinaChin Tradit Herb Drug2004351213971398 53.HuQYangWYLongJEffect"/>
  <result pre="Shenfu injection on procalcitonin and immunoglobulin in elderly patients with" exact="chronic" post="lung infection, ChinaJ Emerg Tradit Chin Med2013225829830 54.LiNShengKJPengGXEffect of"/>
  <result pre="subsided time of clinical symptoms, endothelial cell damage factor and" exact="pulmonary" post="function in elderly patients with severe pneumonia, ChinaPrac Geriatr2019338764767"/>
  <result pre="patients with severe pneumonia, ChinaPrac Geriatr2019338764767 55.LiPHemodynamic effects of severe" exact="pneumonia" post="by Shenfu injection, ChinaGuide Chin Med201210335253 56.LiuXAiFLiHXuQMeiLYMiaoJFet al.Anti-Inflammatory effects"/>
  <result pre="ChinaGuide Chin Med201210335253 56.LiuXAiFLiHXuQMeiLYMiaoJFet al.Anti-Inflammatory effects of Shenfu injection against" exact="acute" post="lung injury through inhibiting HMGB1-NF-kappaB pathway in a rat"/>
  <result pre="via improving their subcellular distributionActa Pharmacol Sin.201738226427610.1038/aps.2016.9927867186 60.LiLYangDLLiJHNiuLChenYZhaoXet al.Investigation of" exact="cardiovascular" post="protective effect of Shenmai injection by network pharmacology and"/>
  <result pre="effect of Shengmai injection combined with conventional Western medicine on" exact="systemic" post="inflammatory response syndrome and its effect on vasoactive transmitter,"/>
  <result pre="injection combined with conventional Western medicine on systemic inflammatory response" exact="syndrome" post="and its effect on vasoactive transmitter, ChinaMod J Integr"/>
  <result pre="Tradit Chin Western Med2018277743746 65.XuJNZhouCHHuangSZComparative observation on treatment of elderly" exact="pulmonary" post="infection with multiple organ failure by adding Shengmai injection(Chinese)J"/>
  <result pre="Chin Western Med2018277743746 65.XuJNZhouCHHuangSZComparative observation on treatment of elderly pulmonary" exact="infection" post="with multiple organ failure by adding Shengmai injection(Chinese)J Modern"/>
  <result pre="mice induced by cyclophosphamideChina Feed Res2014158991 67.DongLLiYQYangSJLiuMNLiuJLA case study on" exact="syndrome" post="differentiation and treatment of new coronavirus pneumoniaChina Pharm Clin"/>
  <result pre="Chin Mater Med202036026971 68.AngLSongELeeHWLeeMSherbal medicine for the treatment of coronavirus" exact="disease" post="2019 (COVID-19): a systematic review and meta-analysis of randomized"/>
  <result pre="Med202095158310.3390/jcm9051583 69.ZhaoLZhaoYFYuanZYSunJBClinical application of Zhang Zhongjing's theory of â€³Treating Different" exact="Diseases" post="with Same Methodâ€³China Tradit Chin Med Res202033024952 70.Xinhuanet. Chinese"/>
 </snippets>
</snippetsTree>
